Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome

Pharmacology and Toxicology

Volumn 89, Issue 6, 2001, Pages 320-325

  Tórsdóttir, Gudlaug ^a,b   Kristinsson, Jakob ^a   Hreidarsson, Stefán ^c   Snaedal, Jón ^b   Jóhannesson, Torkell ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c State Diagnostic and Counselling Center for the Handicapped   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; SUPEROXIDE DISMUTASE;

ADULT; ALZHEIMER DISEASE; ARTICLE; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; COPPER METABOLISM; DEMENTIA; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; CERULOPLASMIN; COPPER; DOWN SYNDROME; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE;

EID: 0035655687     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2001.d01-168.x     Document Type: Article

References (3)

1. Annerén, G. & M. Gebre-Medhin: Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment. Human Nutrition: Clinical Nutrition 1987, 41C, 291-299.
2. Bartelik, S.: Concentration of serum proteins in children with Down syndrome. WiadLek 1992, 45, 682-685 (Polish text with English summary).
3. Boyett, J. D., H. P. Lehmann & M. F. Beeler: Automated assay of ceruloplasmin by kinetic analysis of O-dianisidine oxidation. Acta Clin. Cliem. 1976, 69, 233-241.